Brain neoplasms/radiotherapy
Showing 1 - 25 of >10,000
Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative
Not yet recruiting
- Brain Metastases
- Radiotherapy
- Preoperative Radiotherapy
- +2 more
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
May 12, 2023
Cognitive Impairment, Cognitive Decline, Radiotherapy Side Effect Trial in Solna (Lithium, Placebo)
Not yet recruiting
- Cognitive Impairment
- +6 more
- Lithium
- Placebo
-
Solna, Stockholm, SwedenKarolinska Universitetssjukhuset
Sep 20, 2023
Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)
Recruiting
- Brain Metastases
- +2 more
- brain radiotherapy
- Almonertinib
-
Guangdong, Guangzhou, ChinaSun-Yat-Sen university
Mar 13, 2023
Brain Tumor, Primary, Brain Tumor - Metastatic Trial in Erlangen (brain radiotherapy)
Not yet recruiting
- Brain Tumor, Primary
- Brain Tumor - Metastatic
- brain radiotherapy
-
Erlangen, GermanyErlangen, Universitätsklinikum Strahlenklinik
Oct 24, 2023
Brain Metastases: Value ofLongitudinal Multimodal Approach
Recruiting
- Brain Metastases, Adult
-
Brest, FranceChu Brest
Sep 6, 2023
Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)
Not yet recruiting
- Breast Cancer
- +2 more
- Combination use of SRT with T-DXd
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 14, 2023
Brain Tumor, Brain Necrosis, Brain Metastases Trial in Cleveland (MRF in conjunction with IVIM MRI without contrast)
Not yet recruiting
- Brain Tumor
- +2 more
- MRF in conjunction with IVIM MRI without contrast
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center
Oct 20, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain
Active, not recruiting
- Breast Cancer
- +2 more
- Pyrotinib Plus Capecitabine combined with brain radiotherapy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 14, 2023
Brain Tumor Trial in Memphis (Cognitive training via iPad, Cognitive training via virtual reality)
Recruiting
- Brain Tumor
- Cognitive training via iPad
- Cognitive training via virtual reality
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 13, 2023
Brain Metastases, Adult Trial in Heidelberg (post-operative stereotactic radiosurgery (SRS), Whole brain radiotherapy (WBRT))
Completed
- Brain Metastases, Adult
- post-operative stereotactic radiosurgery (SRS)
- Whole brain radiotherapy (WBRT)
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
Nov 2, 2022
Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)
Recruiting
- Brain Metastases
- Non-small Cell Lung Cancer
- EGFR-TK Inhibitor
- Stereotactic radiotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 27, 2023
Circulating Tumor DNA and T Cell Repertoire Predict
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Brain Metastases
- Whole-brain radiotherapy
-
Wuhan, Hubei, ChinaUnion hospital
Feb 12, 2023
Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- radiotherapy
- Chemotherapy + immunotherapy
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Oct 17, 2022
Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor Trial in Dublin (Dynamic testing of Pituitary Function)
Not yet recruiting
- Hypopituitarism
- +2 more
- Dynamic testing of Pituitary Function
-
Dublin, Ireland
- +1 more
Aug 22, 2023
Stereotactic Radiotherapy for Brain Metastases
Active, not recruiting
- Metastasis Brain
- stereotactic radiotherapy
-
Esch-sur-Alzette, SUD, LuxembourgCentre Francois Baclesse
Jun 20, 2022
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Brain Metastases
- Radiotherapy combined with PD-1 inhibitors
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Nov 27, 2022
Brain Tumor, Brain Cancer Trial in Houston (Standard Fitbit Program, Virtual Exercise Program)
Not yet recruiting
- Brain Tumor
- Brain Cancer
- Standard Fitbit Program
- Virtual Exercise Program
-
Houston, TexasM D Anderson Cancer Center
Sep 26, 2022
Brain Tumor, Metastatic Brain Tumor Trial in New York (Resting-state functional connectivity MRI, Neurocognitive battery with
Recruiting
- Brain Tumor
- Metastatic Brain Tumor
- Resting-state functional connectivity MRI
- Neurocognitive battery with quality-of-life assessment
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 21, 2022
Non Small Cell Lung Cancer, Stage IV NSCLC, Brain Metastases Trial in Hangzhou (Hypofractionated Stereotactic Radiotherap)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Hypofractionated Stereotactic Radiotherap
-
Hangzhou, ChinaKaicheng Pan
Oct 18, 2022
NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Almonertinib
- SBRT
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 23, 2023
Brain Metastases Trial (SRT, fSRT)
Not yet recruiting
- Brain Metastases
- SRT
- fSRT
- (no location specified)
Apr 20, 2022
Brain Metastases, Adult Trial in Switzerland (preoperative radiosurgery, postoperative hypofractionated stereotactic
Recruiting
- Brain Metastases, Adult
- preoperative radiosurgery
- postoperative hypofractionated stereotactic radiotherapy
-
Aarau, Aargau, Switzerland
- +5 more
Sep 7, 2022
Target Therapy for Brain Metastases With EGFR Mutation
Not yet recruiting
- Brain Metastases
- Surgery or Radiotherapy
- before or after target therapy
- (no location specified)
Nov 8, 2022
Brain Metastases Trial in Louisville (intraoperative radiotherapy (IORT))
Terminated
- Brain Metastases
- intraoperative radiotherapy (IORT)
-
Louisville, KentuckyUniversity of Louisville, James Graham Brown Cancer Center
May 17, 2022